Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19374-87-9

Post Buying Request

19374-87-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19374-87-9 Usage

Description

2,5-Pyrrolidinedione, 1-[(hydroxyacetyl)oxy]-, also known as N-(Glycoloyloxy)-succinimide, is an organic compound derived from the synthesis of various pharmaceuticals. It is a key intermediate in the production of certain drugs, particularly those with anti-malarial, anti-rheumatic, and lupus erythematosus suppressant properties.

Uses

Used in Pharmaceutical Industry:
2,5-Pyrrolidinedione, 1-[(hydroxyacetyl)oxy]is used as a key intermediate in the synthesis of Cletoquine (C573505) for its role in the development of anti-malarial, anti-rheumatic, and lupus erythematosus suppressant drugs. Cletoquine is a metabolite of Hydroxychloroquine (H916900), which is known for its effectiveness in treating these conditions.
In the synthesis process, 2,5-Pyrrolidinedione, 1-[(hydroxyacetyl)oxy]serves as a crucial building block, enabling the creation of more complex molecular structures with the desired therapeutic properties. Its use in the pharmaceutical industry is primarily due to its ability to contribute to the development of life-saving and life-enhancing medications.

Check Digit Verification of cas no

The CAS Registry Mumber 19374-87-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,7 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19374-87:
(7*1)+(6*9)+(5*3)+(4*7)+(3*4)+(2*8)+(1*7)=139
139 % 10 = 9
So 19374-87-9 is a valid CAS Registry Number.

19374-87-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2,5-dioxopyrrolidin-1-yl) 2-hydroxyacetate

1.2 Other means of identification

Product number -
Other names 2,5-Pyrrolidinedione,1-[(hydroxyacetyl)oxy]

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19374-87-9 SDS

19374-87-9Relevant articles and documents

Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway

Sangtani, Ajmeeta,Petryayeva, Eleonora,Wu, Miao,Susumu, Kimihiro,Oh, Eunkeu,Huston, Alan L.,Lasarte-Aragones, Guillermo,Medintz, Igor L.,Algar, W. Russ,Delehanty, James B.

, p. 136 - 148 (2018)

Nanoparticle (NP)-mediated drug delivery (NMDD) has emerged as a novel method to overcome the limitations of traditional systemic delivery of therapeutics, including the controlled release of the NP-associated drug cargo. Currently, our most advanced understanding of how to control NP-associated cargos is in the context of soft nanoparticles (e.g., liposomes), but less is known about controlling the release of cargos from the surface of hard NPs (e.g., gold NPs). Here we employ a semiconductor quantum dot (QD) as a prototypical hard NP platform and use intracellularly triggered actuation to achieve spatiotemporal control of drug release and modulation of drug efficacy. Conjugated to the QD are two peptides: (1) a cell-penetrating peptide (CPP) that facilitates uptake of the conjugate into the endocytic pathway and (2) a display peptide conjugated to doxorubicin (DOX) via three different linkages (ester, disulfide, and hydrazone) that are responsive to enzymatic cleavage, reducing conditions, and low pH, respectively. Formation of the QD-[peptide-DOX]-CPP complex is driven by self-assembly that allows control over both the ratio of each peptide species conjugated to the QD and the eventual drug dose delivered to cells. F?rster resonance energy transfer assays confirmed successful assembly of the QD-peptide complexes and functionality of the linkages. Confocal microscopy was employed to visualize residence of the QD-[peptide-DOX]-CPP complexes in the endocytic pathway, and distinct differences in DOX localization were noted for the ester linkage, which showed clear signs of nuclear delivery versus the hydrazone, disulfide, and amide control. Finally, delivery of the QD-[peptide-DOX]-CPP conjugate resulted in cytotoxicity for the ester linkage that was comparable to free DOX. Attachment of DOX via the hydrazone linkage facilitated intermediary toxicity, while the disulfide and amide control linkages showed minimal toxicity. Our data demonstrate the utility of hard NP-peptide bioconjugates to function as multifunctional scaffolds for simultaneous control over cellular drug uptake and toxicity and the vital role played by the nature of the chemical linkage that appends the drug to the NP carrier.

Enzymatic synthesis of trideuterated sialosides

Cai, Zhi-P.,Conway, Louis P.,Huang, Ying Y.,Wang, Wen J.,Laborda, Pedro,Wang, Ting,Lu, Ai M.,Yao, Hong L.,Huang, Kun,Flitsch, Sabine L.,Liu, Li,Voglmeir, Josef

, (2019/04/17)

Sialic acids are a family of acidic monosaccharides often found on the termini of cell surface proteins or lipid glycoconjugates of higher animals. Herein we describe the enzymatic synthesis of the two isotopically labeled sialic acid derivatives d3-X-Gal-a-2,3-Neu5Ac and d3-X-Gal-a-2,3-Neu5Gc. Using deuterium oxide as the reaction solvent, deuterium atoms could be successfully introduced during the enzymatic epimerization and aldol addition reactions when the sialosides were generated. NMR and mass spectrometric analyses confirmed that the resulting sialosides were indeed tri-deuterated. These compounds may be of interest as internal standards in liquid chromatography/mass spectrometric assays for biochemical or clinical studies of sialic acids. This was further exemplified by the use of this tri-deuterated sialosides as internal standards for the quantification of sialic acids in meat and egg samples.

Design and synthesis of active heparan sulfate-based probes

Zhou, Wen,Hsieh, Po-Hung,Xu, Yongmei,O'Leary, Timothy R.,Huang, Xuefei,Liu, Jian

supporting information, p. 11019 - 11021 (2015/07/02)

A chemoenzymatic approach for synthesizing heparan sulfate oligosaccharides with a reactive diazoacetyl saccharide residue is reported. The resultant oligosaccharides were demonstrated to serve as specific inhibitors for heparan sulfate sulfotransferases,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19374-87-9